Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
David Højland Ipsen, Jens Lykkesfeldt, Pernille Tveden‐Nyborg
Cellular and Molecular Life Sciences (2018) Vol. 75, Iss. 18, pp. 3313-3327
Open Access | Times Cited: 1114

Showing 1-25 of 1114 citing articles:

Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 700
NAFLD and cardiovascular diseases: a clinical review
Philipp Kasper, Anna Martin, Sonja Lang, et al.
Clinical Research in Cardiology (2020) Vol. 110, Iss. 7, pp. 921-937
Open Access | Times Cited: 464
The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
Daniela Maria Tănase, Evelina Maria Gosav, Claudia Florida Costea, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 421
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
P. Barton Duell, Francine K. Welty, Michael Miller, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 42, Iss. 6
Open Access | Times Cited: 397
Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
Gopanandan Parthasarathy, Xavier S. Revelo, Harmeet Malhi
Hepatology Communications (2020) Vol. 4, Iss. 4, pp. 478-492
Open Access | Times Cited: 349
Role of Insulin Resistance in MAFLD
Yoshitaka Sakurai, Naoto Kubota, Toshimasa Yamauchi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4156-4156
Open Access | Times Cited: 282
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Kalliopi Pafili, Michael Roden
Molecular Metabolism (2020) Vol. 50, pp. 101122-101122
Open Access | Times Cited: 240
The ménage à trois of autophagy, lipid droplets and liver disease
Yasmina Filali-Mouncef, Catherine J. Hunter, Federica Roccio, et al.
Autophagy (2021) Vol. 18, Iss. 1, pp. 50-72
Open Access | Times Cited: 225
High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms
Cai-Yu Lian, Zhenzhen Zhai, Zifa Li, et al.
Chemico-Biological Interactions (2020) Vol. 330, pp. 109199-109199
Closed Access | Times Cited: 222
Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists
Rohit A. Sinha, Eveline Bruinstroop, Brijesh Kumar Singh, et al.
Thyroid (2019) Vol. 29, Iss. 9, pp. 1173-1191
Open Access | Times Cited: 210
Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress
Yun Ji, Yuan Gao, Hong Chen, et al.
Nutrients (2019) Vol. 11, Iss. 9, pp. 2062-2062
Open Access | Times Cited: 198
The AMPK pathway in fatty liver disease
Chunqiu Fang, Jianheng Pan, Ning Qu, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 180
Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways
Olufunto O. Badmus, Sarah A. Hillhouse, Christopher D. Anderson, et al.
Clinical Science (2022) Vol. 136, Iss. 18, pp. 1347-1366
Open Access | Times Cited: 178
NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment
Johanna K. DiStefano
Endocrinology (2020) Vol. 161, Iss. 10
Open Access | Times Cited: 163
The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease
Guotai Sheng, Song Lu, Qiyang Xie, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 129
Tetramethylpyrazine: A review on its mechanisms and functions
Jianguo Lin, Qingqing Wang, Simin Zhou, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113005-113005
Open Access | Times Cited: 127
Advances in Understanding of the Role of Lipid Metabolism in Aging
Ki Wung Chung
Cells (2021) Vol. 10, Iss. 4, pp. 880-880
Open Access | Times Cited: 117
PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets
Hao Chen, Huabing Tan, Juan Wan, et al.
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108391-108391
Closed Access | Times Cited: 113
Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship
Agnieszka Karkucińska‐Więckowska, Inês C. M. Simões, Piotr Kalinowski, et al.
European Journal of Clinical Investigation (2021) Vol. 52, Iss. 3
Open Access | Times Cited: 105
SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection
Θεόδωρος Ανδρουτσάκος, Narjes Nasiri‐Ansari, Athanasios‐Dimitrios Bakasis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3107-3107
Open Access | Times Cited: 98
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Luis Antonio Díaz, Juan Pablo Arab, Alexandre Louvet, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 764-783
Closed Access | Times Cited: 96
Tolerable upper intake level for dietary sugars
Dominique Turck, Torsten Bohn, Jacqueline Castenmiller, et al.
EFSA Journal (2022) Vol. 20, Iss. 2
Open Access | Times Cited: 83
Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease
Yanhua Chen, Xiaomeng Du, Annapurna Kuppa, et al.
Nature Genetics (2023) Vol. 55, Iss. 10, pp. 1640-1650
Open Access | Times Cited: 83
Mitochondrial pyruvate carrier 1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease
Ruxin Gao, Yue Li, Zhimeng Xu, et al.
Hepatology (2023) Vol. 78, Iss. 6, pp. 1800-1815
Closed Access | Times Cited: 77
Inhibition of Fatty Acid Translocase (FAT/CD36) Palmitoylation Enhances Hepatic Fatty Acid β-Oxidation by Increasing Its Localization to Mitochondria and Interaction with Long-Chain Acyl-CoA Synthetase 1
Shu Zeng, Fan Wu, Mengyue Chen, et al.
Antioxidants and Redox Signaling (2022) Vol. 36, Iss. 16-18, pp. 1081-1100
Closed Access | Times Cited: 72
Page 1 - Next Page

Scroll to top